- FORTH at a glance
- Central Administration
- Crete University Press
- Science & Technology Park of Crete
- FORTH Internal Committees
- PRAXI Network
- Liaison Office
- Researchers - Personnel
- The Disk of Phaistos
- Institute of Electronic Structure & Laser
- Institute of Molecular Biology & Biotechnology
- Institute of Computer Science
- Institute of Applied and Computational Mathematics
- Institute for Mediterranean Studies
- Institute of Chemical Engineering Sciences
- Institute of Astrophysics
- Institute of Petroleum Research
News > Announcements
Page 2 of 52
Select YearAll | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
ELECTION OF DIRECTOR AT THE INSTITUTE OF CHEMICAL ENGINEERING SCIENCES OF FORTH
Feb 20, 2019Dr. Vassilis Burganos, was re-elected Director of the Institute of Chemical Engineering Sciences of FORTH on February 15, 2019 for a second term.
ELECTION OF DIRECTOR AT THE INSTITUTE OF ASTROPHYSICS OF FORTH
Jan 23, 2019Dr. Vassilis Charmandaris, Professor of Observational Astrophysics at the Dept. of Physics of the University of Crete and Associated Researcher of the Institute of Electronic Structure and Laser (IESL) of FORTH, was elected Director of the Institute of Astrophysics (IA) of FORTH on January 22, 2019.
ELECTION OF DIRECTOR AT THE INSTITUTE OF ELECTRONIC STRUCTURE AND LASER OF FORTH
Nov 22, 2018Dr. Spiros H. Anastasiadis, Professor of Polymer Science & Engineering at the Dept. of Chemistry of the University of Crete, was re-elected Director of the Institute of Electronic Structure and Laser (IESL) of FORTH on November 12, 2018 for a second term.
FORTH is a partner on a Future Emerging Technologies (FET) Flagship proposal focused on “Personalised Health Care”
Feb 13, 2018FORTH is on the Steering Committee of a Future Emerging Technologies (FET) Flagship proposal, the Personalised Health Care Initiative in Europe. The Personalised Health Care Initiative is a large-scale scientific and technological proposal that will address the grand challenge of developing regenerative, precision and personalised medicine to improve the quality of life of billions of patients worldwide.